Kim Ye-Seul, Kang Hee-Taik, Lee Jae-Woo
Department of Family Medicine, Chungbuk National University Hospital, Cheongju, Korea.
Department of Family Medicine, Chungbuk National University College of Medicine, Cheongju, Korea.
Korean J Fam Med. 2019 Sep;40(5):307-313. doi: 10.4082/kjfm.18.0074. Epub 2019 Sep 6.
Cancer survivors are at a higher risk of primary cancer recurrence and development of second primary cancer. In both cases, early disease detection is crucial. This cross-sectional study assessed cancer screening participation rates according to cancer history.
Data were obtained from the 2010-2012 Korea National Health and Nutrition Examination Survey for 12,500 participants. Of these, 624 cancer survivors were enrolled in this study. Sampling weights were applied to maintain the representativeness of the Korean adult population.
Overall 2-year cancer screening rates prior to the survey in male and female cancer survivors were 59.9% and 73.7%, respectively, while opportunistic cancer screening rates were 33.5% and 52.1%, respectively. The odds ratios (95% confidence interval) of the overall cancer screening among the cancer survivors, compared to others, were 1.16 (0.79-1.72) in male and 1.78 (1.20-2.63) in female participants, after the adjustment for confounding variables. The odds ratios (95% confidence interval) for opportunistic cancer screening and National Cancer Screening Program among cancer survivors were 1.56 (1.07-2.27) and 0.80 (0.53-1.21) in males and 2.05 (1.46-2.88) and 0.66 (0.46-0.95) in females.
Female cancer survivors showed a higher rate of overall and opportunistic cancer screening than did the male cancer survivors. Further efforts are required to improve cancer screening among male cancer survivors.
癌症幸存者患原发性癌症复发和继发原发性癌症的风险更高。在这两种情况下,早期疾病检测都至关重要。这项横断面研究根据癌症病史评估了癌症筛查参与率。
数据来自2010 - 2012年韩国全国健康与营养检查调查的12500名参与者。其中,624名癌症幸存者纳入本研究。应用抽样权重以维持韩国成年人群的代表性。
在调查前,男性和女性癌症幸存者的总体2年癌症筛查率分别为59.9%和73.7%,而机会性癌症筛查率分别为33.5%和52.1%。在调整混杂变量后,与其他人群相比,癌症幸存者中男性总体癌症筛查的优势比(95%置信区间)为1.16(0.79 - 1.72),女性为1.78(1.20 - 2.63)。癌症幸存者中男性机会性癌症筛查和国家癌症筛查计划的优势比(95%置信区间)分别为1.56(1.07 - 2.27)和0.80(0.53 - 1.21),女性分别为2.05(1.46 - 2.88)和0.66(0.46 - 0.95)。
女性癌症幸存者的总体和机会性癌症筛查率高于男性癌症幸存者。需要进一步努力提高男性癌症幸存者的癌症筛查率。